Skip to main content

Advertisement

Log in

The pathogenicity of a US3 protein kinase-deficient mutant of herpes simplex virus type 2 in mice

  • Original Papers
  • Published:
Archives of Virology Aims and scope Submit manuscript

Summary

We have investigated the pathogenicity of a US3 protein kinase-deficient mutant (L1 BR1) of herpes simplex virus type 2 (HSV-2) for 4-week-old ICR mice to define the role of the viral protein kinase in virus-host interaction. When mice were intraperitoneally infected with 105 PFU of L1 BR1, the virus disappeared from the peritoneal cavity by 2 days postinfection and failed to induce any significant histopathological changes in the liver and spleen although viral antigens were occasionally detected in the epithelial cells of small bile ducts and small vascular wall. The parental virus (HSV-2 186) and a revertant of the mutant (L1 B11) both caused severe hepatitis, and viral antigens were clearly detected in the hepatocytes and Kupffer cells in the focal necrotic areas. Both of the virulent viruses, unlike L1 BR1, could produce infectious progeny and cytopathic effects in freshly harvested peritoneal macrophages. The growth of L1 BR1 in peritoneal macrophages was restricted at a stage of or prior to viral DNA synthesis but after the induction of viral DNA polymerase. In addition, the production and/or the spread of the mutant in mouse embryo fibroblasts (MEF) was found to be much more effectively suppressed by cocultivation of peritoneal macrophages than that of 186. An almost complete inhibition of L1 BR1-plaque formation was observed at a macrophage-to-MEF ratio of 4:1. These results suggest that the attenuation of L1 BR1 following intraperitoneal infection is primarily due to its high sensitivity to intrinsic and extrinsic inhibition of peritoneal macrophages and that the US 3 protein kinase may play a role in viral DNA replication in peritoneal macrophages.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Chou J, Kern ER, Whitley RJ, Roizman B (1990) Mapping of herpes simplex virus 1 neurovirulence to γ 1 34.5, a gene non-essential for growth in culture. Science 250: 1262–1266

    Google Scholar 

  2. Daikoku T, Yamamoto N, Saito S, Kitagawa M, Shimada N, Nishiyama Y (1991) Mechanism of inhibition of human cytomegalovirus replication by oxetanocin G. Biochem Biophys Res Commun 176: 805–812

    Google Scholar 

  3. Dix RD, McKendall RR, Baringer JR (1983) Comparative neurovirulence of herpes simplex virus type 1 strains after peripheral or intracerebral inoculation of BALB/c mice. Infect Immun 40: 103–112

    Google Scholar 

  4. Hayashi K, Kurata T, Morishima T, Nassery T (1980) Analysis of the inhibitory effect of peritoneal macrophages on the spread of herpes simplex virus. Infect Immun 28: 350–358

    Google Scholar 

  5. Izumi KM, Stevens JG (1990) Molecular and biological characterization of a herpes simplex virus type 1 (HSV-1) neuroinvasiveness gene. J Exp Med 172: 487–496

    Google Scholar 

  6. Jacobson JG, Leib DA, Goldstein DJ, Bogard CL, Schaffer PA, Weller SK, Coen DM (1989) A herpes simplex virus ribonucleotide reductase deletion mutant is defective for productive acute and reactivatable latent infections of mice and replication in mouse cells. Virology 173: 276–283

    Google Scholar 

  7. Johnson RT (1964) The pathogenesis of herpes encephalitis. II. A cellular basis for the development of resistance with age. J Exp Med 120: 359–374

    Google Scholar 

  8. Käerner HC, Schröder CH, Ott-Hartmann A, Kümel G, Kirchner H (1983) Genetic variability of herpes simplex virus: development of a pathogenic variant during passaging of a non-pathogenic herpes simplex virus type 1 virus strain in mouse brain. J Virol 46: 83–93

    Google Scholar 

  9. Lopez C, Dudas G (1979) Replication of herpes simplex virus type 1 in macrophages from resistant and susceptible mice. Infect Immun 23: 432–437

    Google Scholar 

  10. Lopez C (1981) Resistance to herpes simplex virus type 1 (HSV-1). Curr Top Microbiol Immunol 92: 15–24

    Google Scholar 

  11. Lopez C (1985) Natural resistance mechanisms in herpes simplex virus infections. In: Roizman B, Lopez C (eds) The herpesviruses, vol 4. Plenum Press, New York, pp 37–68

    Google Scholar 

  12. Morahan P, Morse SS, McGeorge MB (1980) Macrophage extrinsic antiviral activity during herpes simplex virus infection. J Gen Virol 46: 291–300

    Google Scholar 

  13. Morahan PS, Connor JR, Leary KR (1985) Viruses and the versatile macrophage. Br Med Bull 41: 15–21

    Google Scholar 

  14. Nishiyama Y, Rapp F (1981) Repair replication of viral and cellular DNA in herpes simplex virus type 2-infected human embryonic and xeroderma pigmentosum cells. Virology 110: 466–475

    Google Scholar 

  15. Nishiyama Y, Kimura H, Daikoku T (1991) Complementary lethal invasion of the central nervous system by non-neuroinvasive herpes simplex virus types 1 and 2. J Virol 65: 4520–4524

    Google Scholar 

  16. Nishiyama A, Yamada Y, Kurachi R, Daikoku T (1992) Construction of a US 3 lacZ insertion mutant of herpes simplex virus type 2 and characterization of its phenotype in vitro and in vivo. Virology 190: 256–268

    Google Scholar 

  17. Purves FC, Spector D, Roizman B (1991) The herpes simplex virus 1 protein kinase encoded by the US 3 gene mediates post-translational modification of the phosphoprotein encoded by the UL 34 gene. J Virol 65: 5757–5764

    Google Scholar 

  18. Pyles RB, Sawtell NM, Thompson RL (1992) Herpes simplex virus type 1 dUTPase mutants are attenuated for neurovirulence, neuroinvasiveness, and reactivation from latency. J Virol 66: 6706–6713

    Google Scholar 

  19. Samiento M (1988) Intrinsic resistance to viral infection: mouse macrophage restriction of herpes simplex virus replication. J Immunol 141: 2740–2748

    Google Scholar 

  20. Sata T, Kurata T, Aoyama Y, Sakaguchi M, Yamanouchi K, Takeda K (1986) Analysis of viral antigens in giant cells of measles pneumonia by immunoperoxidase method. Virchows Arch A Pathol Anat Histopathol 410: 133–138

    Google Scholar 

  21. Schröder CH, Kümel G (1986) Virulent and avirulent HSV-1: pathogenesis and molecular biology. In: Lopez C, Roizman B (eds) Human herpesvirus infection. Raven Press, New York, pp 12–23

    Google Scholar 

  22. Stevens JC, Cook ML (1971) Restriction of herpes simplex virus by macrophages. An analysis of cell-virus interactions. J Exp Med 133: 19–38

    Google Scholar 

  23. Tenser RB, Ressel S, Dunstan ME (1981) Herpes simplex virus thymidine kinase expression in trigeminal ganglia infection: correlation of enzyme activity with ganglion virus titer and evidence of in vivo complementation. Virology 112: 328–341

    Google Scholar 

  24. Yamada Y, Kimura H, Morishima T, Daikoku T, Maeno K, Nishiyama Y (1991) The pathogenicity of ribonucleotide reductase-null mutants of herpes simplex virus type 1 in mice. J Infect Dis 164: 1091–1097

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kurachi, R., Daikoku, T., Tsurumi, T. et al. The pathogenicity of a US3 protein kinase-deficient mutant of herpes simplex virus type 2 in mice. Archives of Virology 133, 259–273 (1993). https://doi.org/10.1007/BF01313767

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01313767

Keywords

Navigation